Terns Pharmaceuticals Inc
F:430
Terns Pharmaceuticals Inc
F:430
Kurs:
45,07
EUR
Markt geschlossen
Marktkap.:
€2,75 Mrd.
Notiz hinzufügen
Kursziel hinzufügen
Gedanken festhalten und ein Kursziel setzen
Legen Sie fest, zu welchem Kurs Sie kaufen würden. Wir helfen Ihnen, bereit zu bleiben.
Basierend auf
Sicherheitsmarge
0%
10%
20%
30%
40%
50%
Ihr Kursziel
Verknüpft mit
aktuellem Kurs
· In Kaufzone
Lädt
Notiz verknüpft
Wählen Sie die Aktie, die Sie mit einem Kursziel beobachten möchten
Zuletzt angesehen
|
Terns Pharmaceuticals Inc
F:430
|
US |
Cashflow-Rechnung
Cashflow-Rechnung
Terns Pharmaceuticals Inc
Terns Pharmaceuticals Inc
Währung: USD
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operativer Cashflow | ||||||||||||||||||||||||
| Nettogewinn |
(88)
|
(41)
|
(41)
|
(45)
|
(46)
|
(46)
|
(50)
|
(51)
|
(54)
|
(59)
|
(60)
|
(68)
|
(72)
|
(85)
|
(90)
|
(91)
|
(96)
|
(88)
|
(89)
|
(90)
|
(92)
|
(94)
|
(96)
|
|
| Abschreibungen |
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
(0)
|
(0)
|
0
|
|
| Veränderung latenter Steuern |
0
|
0
|
1
|
1
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
|
| Aktienbasierte Vergütung |
1
|
2
|
2
|
3
|
5
|
6
|
8
|
9
|
10
|
11
|
11
|
12
|
14
|
25
|
26
|
26
|
26
|
16
|
16
|
15
|
14
|
13
|
13
|
|
| Sonstige nicht zahlungswirksame Posten |
1
|
1
|
5
|
6
|
8
|
10
|
9
|
11
|
11
|
12
|
11
|
11
|
12
|
21
|
21
|
22
|
22
|
14
|
14
|
14
|
13
|
12
|
14
|
|
| Gezahlte Steuern |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Veränderung des Working Capital |
4
|
7
|
5
|
1
|
(0)
|
(4)
|
(1)
|
(2)
|
(2)
|
(2)
|
(1)
|
6
|
8
|
4
|
1
|
(7)
|
(6)
|
(1)
|
4
|
4
|
4
|
4
|
(0)
|
|
| Cashflow aus operativer Tätigkeit |
(82)
N/A
|
(32)
+61%
|
(30)
+7%
|
(37)
-24%
|
(37)
+0%
|
(39)
-5%
|
(42)
-9%
|
(41)
+2%
|
(43)
-6%
|
(49)
-12%
|
(49)
-1%
|
(50)
-2%
|
(52)
-4%
|
(59)
-14%
|
(67)
-14%
|
(76)
-12%
|
(79)
-4%
|
(74)
+6%
|
(70)
+6%
|
(72)
-2%
|
(74)
-4%
|
(78)
-5%
|
(82)
-5%
|
|
| Investitions-Cashflow | ||||||||||||||||||||||||
| Investitionsausgaben |
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Sonstige Posten |
4
|
12
|
7
|
(97)
|
(118)
|
(113)
|
(119)
|
(13)
|
(8)
|
(14)
|
(22)
|
(4)
|
(79)
|
(100)
|
(38)
|
(58)
|
75
|
129
|
(12)
|
(18)
|
(35)
|
(42)
|
(298)
|
|
| Cashflow aus Investitionstätigkeit |
3
N/A
|
11
+274%
|
7
-38%
|
(97)
N/A
|
(118)
-21%
|
(113)
+4%
|
(120)
-6%
|
(13)
+89%
|
(8)
+37%
|
(14)
-67%
|
(22)
-57%
|
(4)
+83%
|
(79)
-1.955%
|
(100)
-27%
|
(38)
+62%
|
(58)
-52%
|
75
N/A
|
129
+72%
|
(12)
N/A
|
(18)
-49%
|
(35)
-89%
|
(42)
-21%
|
(298)
-602%
|
|
| Finanzierungs-Cashflow | ||||||||||||||||||||||||
| Nettoausgabe von Stammaktien |
0
|
0
|
70
|
206
|
206
|
207
|
137
|
1
|
1
|
61
|
168
|
195
|
196
|
135
|
42
|
14
|
14
|
178
|
164
|
164
|
164
|
1
|
744
|
|
| Nettoaufnahme von Schulden |
17
|
17
|
17
|
17
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Sonstiges |
0
|
(0)
|
(1)
|
(2)
|
(4)
|
(4)
|
(3)
|
(2)
|
0
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Cashflow aus Finanzierungstätigkeit |
17
N/A
|
17
0%
|
86
+408%
|
221
+158%
|
202
-8%
|
203
+0%
|
134
-34%
|
(1)
N/A
|
1
N/A
|
61
+6.474%
|
167
+173%
|
195
+17%
|
195
+0%
|
134
-31%
|
42
-69%
|
14
-66%
|
14
-1%
|
178
+1.145%
|
164
-8%
|
164
+0%
|
164
0%
|
0
-100%
|
744
+192.022%
|
|
| Veränderung der Zahlungsmittel | ||||||||||||||||||||||||
| Effekt von Wechselkursänderungen |
(0)
|
1
|
0
|
0
|
0
|
(0)
|
(0)
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
0
|
|
| Nettoveränderung der Zahlungsmittel |
(63)
N/A
|
(4)
+94%
|
62
N/A
|
87
+39%
|
48
-45%
|
51
+6%
|
(27)
N/A
|
(55)
-102%
|
(51)
+8%
|
(2)
+96%
|
96
N/A
|
140
+47%
|
64
-54%
|
(25)
N/A
|
(63)
-152%
|
(119)
-88%
|
10
N/A
|
233
+2.147%
|
82
-65%
|
74
-9%
|
55
-26%
|
(120)
N/A
|
363
N/A
|
|
| Free Cashflow | ||||||||||||||||||||||||
| Free Cashflow |
(84)
N/A
|
(33)
+61%
|
(30)
+7%
|
(37)
-22%
|
(37)
+0%
|
(39)
-5%
|
(42)
-9%
|
(41)
+2%
|
(44)
-6%
|
(49)
-12%
|
(49)
-1%
|
(50)
-2%
|
(52)
-4%
|
(59)
-14%
|
(67)
-14%
|
(76)
-13%
|
(79)
-4%
|
(74)
+6%
|
(70)
+6%
|
(72)
-2%
|
(74)
-4%
|
(78)
-5%
|
(82)
-5%
|
|
Wechseln zu:
Wechseln zu:
Auch interessant
Other Terns Pharmaceuticals Inc listings:
Mehr entdecken
